Eve Health Group (EVE.AX) Stock Price
Eve Health Group Price
Over the last 19 years Eve Health Group grew revenue by 5.2% annually, reaching 1.15 M AUD. For Eve Health Group, the net margin of -164.0% is up versus -267.4% a few years ago.
Eve Health Group stock price
Eve Health Group business model & stock analysis
Frequently asked questions about Eve Health Group
Converted at the current exchange rate, the Eve Health Group share trades at 0.01 EUR (0.01 AUD).
The revenue of Eve Health Group is 1.15 M AUD. This figure is based on current financial data and reflects the company's business performance.
The profit of Eve Health Group is -1.89 M AUD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Eve Health Group is currently -2.55. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Eve Health Group stock.
The price-to-sales ratio (P/S) of Eve Health Group is currently 4.18. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Eve Health Group stock.
The Eulerpool Quality Score for Eve Health Group is 3/10.
The ISIN of Eve Health Group is AU000000EVE3. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Eve Health Group is EVE.AX. The ticker symbol is used to trade Eve Health Group shares on the stock exchange.
Eve Health Group stock
Eve Health Group Peer Group
Eve Health Group FIGI
All fundamentals and in-depth analysis of Eve Health Group
Our stock analysis for Eve Health Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eve Health Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.